This post was originally published on this site
This in turn led to tepid demand for cannabis products, high inventory levels, widening losses, and multi-billion-dollar goodwill write-downs. Further, in order to offset cash burn, cannabis companies have raised equity capital several times, which has diluted shareholder wealth and contributed to their stock decline.
However, the marijuana market in Canada continues to expand and cannabis legalization efforts around the world makes these stocks compelling bets for long-term growth investors. In this article I’m going to analyze two canadian cannabis stocks, Sundial (SNDL) and Cronos (CRON), to see which is the better buy now.
